| 1 |
32606720 | The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy. | 2020 |
1 |
| 2 |
30030468 | CYP2C9 and OATP1B1 genetic polymorphisms affect the metabolism and transport of glimepiride and gliclazide. | 2018 Jul 20 |
5 |
| 3 |
27181593 | CYP2C93 variant is associated with antidiabetes efficacy of gliclazide in Chinese type 2 diabetes patients. | 2016 Sep |
1 |
| 4 |
21356265 | Reduced catalytic activity of human CYP2C9 natural alleles for gliclazide: molecular dynamics simulation and docking studies. | 2011 Jun |
7 |
| 5 |
21691805 | Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting. | 2011 Dec |
2 |
| 6 |
20831536 | Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers. | 2010 Jun |
3 |
| 7 |
18541345 | The metabolism of CYP2C9 and CYP2C19 for gliclazide by homology modeling and docking study. | 2009 Feb |
6 |
| 8 |
19891554 | Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas. | 2009 Nov |
1 |
| 9 |
18204476 | Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. | 2008 Apr |
1 |
| 10 |
17298483 | Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects. | 2007 Jul |
3 |
| 11 |
14534520 | Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide. | 2003 Oct |
2 |